Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-020-03490-6
Abstract: Imatinib, a small-molecule tyrosine kinase inhibitor, has shown good clinical activity by inhibiting adenosine triphosphate (ATP) binding to the receptor. Unfortunately, majority of patients eventually develop drug resistance, which limits the long-term benefits of the…
read more here.
Keywords:
inhibits kit;
kit;
kit dimer;
dimerisation ... See more keywords